ImmunityBio, Inc.

IBRXNASDAQHealthcare● Active

$7.18

+$0.26(+3.76%)

Market Cap$7.5B

P/E Ratio—

52W High$12.43

52W Low$1.95

Avg Volume18.1M

Open$7.12

Beta0.10

Overview

ImmunityBio, Inc. (IBRX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · IBRX · as of Feb 23, 2026

Latest filing snapshot

691

+11+1.62%vs prior year

ImmunityBio, Inc. (IBRX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

691

Change (1Y)

+11

Growth % (1Y)

+1.62%

Revenue / Employee

$163.9K

Net Income / Employee

$-508.5K

Market Cap

$7.6B

IBRX Employee Count

2015 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-23	2025-12-31	691	+11	+1.62%
2025-03-03	2024-12-31	680	+52	+8.28%
2024-03-19	2023-12-31	628	-97	-13.38%
2023-03-01	2022-12-31	725	+138	+23.51%
2022-03-01	2021-12-31	587	+416	+243.27%
2021-03-04	2020-12-31	171	+23	+15.54%
2020-03-25	2019-12-31	148	-13	-8.07%
2019-03-13	2018-12-31	161	+22	+15.83%
2018-03-12	2017-12-31	139	+57	+69.51%
2017-03-15	2016-12-31	82	+51	+164.52%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Agios Pharmaceuticals, Inc.

486$1.6B #4

DNLI

Denali Therapeutics Inc.

443$3.1B #5

BEAM

Beam Therapeutics Inc.

393$3.0B #6

COGT

Cogent Biosciences, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · IBRX peer comparison

About IBRX employees

IBRX Employees · Headcount

ImmunityBio, Inc. (IBRX) employee data is sourced from the annual SEC 10-K filing. As of 2025, ImmunityBio, Inc. had 691 full-time employees globally. Full-time employees only. Global consolidated headcount.

ImmunityBio, Inc. employs 691 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $163,948, reflecting the company's operational efficiency.

ImmunityBio, Inc.'s workforce increased by 11 (1.62%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

ImmunityBio, Inc.'s revenue per employee of $163,948 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

IBRX Employees · 5 questions

As of the latest SEC 10-K filing (2025), ImmunityBio, Inc. had 691 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

ImmunityBio, Inc. employee counthow many employees does ImmunityBio, Inc. haveIBRX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-23